. Whoqol-group, Development of the WHOQOL: Rational and current status, Int. J Mental Health, vol.23, pp.24-56, 1994.

, World Health Organization. WHOQOL-BREF introduction, administration, scoring and generic version of the assessment. Geneva: World Health Organization, 1996.

, International classification of functioning, disability and health (ICF)

V. Strand and J. A. Singh, Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity, Drugs, vol.70, pp.121-166, 2010.

J. A. Singh and V. Strand, Spondyloarthritis is associated with poor function and physical health-related quality of life, J Rheumatol, vol.36, pp.1012-1020, 2009.

K. B. Sokoll and P. S. Helliwell, Comparison of disability and quality of life in rheumatoid and psoriatic arthritis, J Rheumatol, vol.28, pp.1842-1846, 2001.

J. A. Husted, D. D. Gladman, and V. T. Farewell, Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis, Arthritis Rheum, vol.45, pp.151-158, 2001.

P. Borman, G. G. Toy, and S. Babaoglu, A comparative evaluation of quality of life and life satisfaction in patients with psoriatic and rheumatoid arthritis, Clin Rheumatol, vol.26, pp.330-334, 2007.

N. Ovayolu, O. Ovayolu, and G. Karadag, Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy ?ndividuals, Clin Rheumatol, vol.30, pp.655-664, 2011.

F. Salaffi, P. Sarzi-puttini, and R. Girolimetti, Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey, Clin Exp Rheumatol, vol.27, issue.5, 2009.

F. Salaffi, M. Carotti, and S. Gasparini, The health related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people, Health Qual Life Outcome, vol.7, p.25, 2009.

D. D. Gladman, C. Antoni, and P. Mease, Psoriatic arthritis: epidemiology, clinical features, course, and outcome, Ann Rheum Dis, vol.64, issue.2, pp.14-21, 2005.

V. Strand, V. Sharp, and A. S. Koenig, Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatment, Ann Rheum Dis, vol.71, pp.1143-1150, 2012.

, PsA and psoriasis, demonstrating different patterns of QoL profiles across these diseases, and bringing new perspectives in understanding how the two components of PsA (arthritis and skin disease) impact patients, p.31

W. J. Taylor, Impact of psoriatic arthritis on the patient: through the lens of the WHO International Classification of Functioning, Health, and Disability, Curr Rheumatol Rep, vol.14, pp.369-374, 2012.

T. Gudu, U. Kiltz, and M. De-wit, Mapping the Effect of Psoriatic Arthritis Using the International Classification of Functioning, Disability and Health, J Rheumatol, vol.44, pp.193-200, 2017.

*. , Article that reviewed qualitative PsA publications and linked them to the ICF, showing that PsA widely affects all aspects of patients' lives

W. Tillett, A. Adebajo, and M. Brooke, Patient involvement in outcome measures for psoriatic arthritis, Curr Rheumatol Rep, vol.16, p.418, 2014.

T. A. Stamm, V. Nell, and M. Mathis, Concepts important to patients with psoriatic arthritis are not adequately covered by standard measures of functioning, Arthritis Rheum, vol.57, pp.487-494, 2007.

*. , Qualitative study on PsA patients' problems in daily functioning demonstrating that there are several concepts addressing participation that are currently not covered in the instruments assessing functioning in PsA

A. R. Moverley, K. A. Vinall-collier, and P. S. Helliwell, It's not just the joints, it's the whole thing: qualitative analysis of patients' experience of flare in psoriatic arthritis, Rheumatology, vol.54, pp.1448-1153, 2015.

E. Dures, S. Hewlett, and J. Lord, Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study, Patient, vol.10, p.32, 2017.

A. Szentpetery, M. A. Johnson, and C. T. Ritchlin, GRAPPA Trainees Symposium 2013: a report from the GRAPPA 2013 Annual Meeting, vol.41, pp.1200-1205, 2014.

L. Gossec, Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective (ReFlaP, NCT03119805?term=NCT03119805&rank=1 (Identification No NCT03119805 ), 2017.

M. Boers, J. R. Kirwan, and G. Wells, Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0, J Clin Epidemiol, vol.67, pp.745-53, 2014.

M. P. De-wit, S. E. Berlo, and G. J. Aanerud, European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects, Ann Rheum Dis, vol.70, pp.722-728, 2011.

L. Gossec, M. De-wit, and U. Kiltz, A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative, Ann Rheum Dis, vol.73, pp.1012-1019, 2014.

, ** Patient-derived instrument (questionnaire) to assess PsA impact, applicable in daily practice, with active involvement of patients at several levels throughout

S. P. Mckenna, L. C. Doward, and D. Whalley, Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis, Ann Rheum Dis, vol.63, pp.162-169, 2004.

T. , J. C. Gratacos, J. , and R. Js, Development and validation of a new instrument to measure health-related quality of life in patients with psoriatic arthritis: the VITACORA-19, J Rheumatol, vol.41, p.33, 2014.

W. J. Taylor, P. J. Mease, and A. Adebajo, Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health, J Rheumatol, vol.3, pp.1885-1891, 2010.

G. Stucki, A. Cieza, and S. Geyh, ICF Core Sets for rheumatoid arthritis, J Rehabil Med, vol.44, pp.87-93, 2004.

A. Boonen, J. Braun, H. Van-der, and I. E. Bruinsma, ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health, Ann Rheum Dis, vol.69, pp.102-107, 2010.

W. Tillett, C. De-vries, and M. , Work disability in psoriatic arthritis: a systematic review, Rheumatology (Oxford), vol.51, pp.275-283, 2012.

W. Tillett, G. Shaddick, and A. Askari, Factors influencing work disability in psoriatic arthritis: first results from a large UK multicentre study, Rheumatology (Oxford), vol.54, pp.157-162, 2015.

M. Kennedy, A. Papneja, and A. Thavaneswaran, Prevalence and predictors of reduced work productivity in patients with psoriatic arthritis, Clin Exp Rheumatol, vol.32, pp.342-348, 2014.

J. A. Walsh, M. L. Mcfadden, and M. D. Morgan, Work productivity loss and fatigue in psoriatic arthritis, J Rheumatol, vol.41, pp.1670-1674, 2014.

F. Siannis, V. T. Farewell, and R. J. Cook, Clinical and radiological damage in psoriatic arthritis, Ann Rheum Dis, vol.65, pp.478-481, 2006.

S. W. Hu, E. W. Holt, and M. E. Husni, Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study, Semin Arthritis Rheum, vol.39, pp.384-397, 2010.

P. Putrik, S. Ramiro, and M. Hifinger, In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study, Ann Rheum Dis, vol.75, pp.715-720, 2016.

M. Freire, J. Rodriguez, and I. Moller, Prevalence of symptoms of anxiety and depression in patients with psoriatic arthritis attending rheumatology clinics

, Reumatol Clin, vol.7, pp.20-26, 2011.

M. Khraishi, D. Macdonald, and E. Rampakakis, Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts, Clin Rheumatol, vol.30, pp.877-885, 2011.

J. A. Husted, A. Thavaneswaran, and V. Chandran, Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis, Arthritis Care Res, vol.63, pp.1729-1735, 2011.

K. Kotsis, P. V. Voulgari, and N. Tsifetaki, Anxiety and depressive symptoms and illness perceptions in psoriatic arthritis and associations with physical health-related quality of life, Arthritis Care Res, vol.64, pp.1593-1601, 2012.

E. Mcdonough, R. Ayearst, and L. Eder, Depression and anxiety in psoriatic disease: prevalence and associated factors, J Rheumatol, vol.41, pp.887-896, 2014.

F. Bandinelli, F. Prignano, and D. Bonciani, Clinical and demographic factors influence on anxiety and depression in early psoriatic arthritis (ePsA), Clin Exp Rheumatol, vol.31, pp.318-319, 2013.

J. Schmitt and D. E. Ford, Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and 35 depressive symptoms in patients with psoriasis -a structural equations modeling approach, Gen Hosp Psychiatry, vol.29, pp.134-140, 2007.

B. Michelsen, E. K. Kristianslund, and J. Sexton, Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. A n n R h e u m D i s, vol.76, pp.1906-1910, 2017.

N. Betteridge, W. H. Boehncke, and C. Bundy, Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience, J Eur Acad Dermatol Venereol, vol.30, pp.576-585, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01427089

M. Uttjek, L. Nygren, and B. Stenberg, Marked by visibility of psoriasis in everyday life, Qual Health Res, vol.17, pp.364-372, 2007.

J. A. Husted, B. D. Tom, and C. T. Schentag, Occurrence and correlates of fatigue in psoriatic arthritis, Ann Rheum Dis, vol.68, pp.1553-1558, 2009.

T. Gudu, A. Etcheto, and M. De-wit, Fatigue in psoriatic arthritis -a cross-sectional study of 246 patients from 13 countries, Joint Bone Spine, vol.83, pp.439-443, 2016.

P. E. Palominos, C. Gaujoux-viala, and B. Fautrel, Clinical outcomes in psoriatic arthritis: A systematic literature review, Arthritis Care Res (Hoboken), vol.64, pp.397-406, 2012.

J. A. Husted, B. D. Tom, and V. T. Farewell, Longitudinal analysis of fatigue in psoriatic arthritis, J Rheumatol, vol.37, pp.1878-1884, 2010.

C. Carneiro, M. Chaves, and G. Verardino, Evaluation of fatigue and its correlation with quality of life index, anxiety symptoms, depression and activity of disease in patients with psoriatic arthritis, Clin Cosmet Investig Dermatol, vol.10, p.36, 2017.

D. D. Gladman, P. J. Mease, and V. Strand, Consensus on a core set of domains for psoriatic arthritis, J Rheumatol, vol.34, pp.1167-1170, 2007.

A. M. Orbai, M. De-wit, and P. Mease, International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials, Ann Rheum Dis, vol.76, pp.673-680, 2017.

. **-the, Several patient-reported domains, e.g., fatigue, emotional well-being, participation have been included in this list, 2016.

U. Kalyoncu, A. Ogdie, and W. Campbell, Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. RMD Open2016;2:e000217 * Systematic literature review on domains assessed in PsA studies showing an increasing trend towards reporting domains that are important for PsA patients: fatigue, productivity, and to a lesser extent participation

N. Tezel, Y. Tasdelen, O. Bodur, and H. , Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?, Int J Rheum Dis, vol.18, pp.63-69, 2015.

C. F. Rosen, F. Mussani, and V. Chandran,

, Rheumatology (Oxford), vol.51, pp.571-576, 2012.

L. Lundberg, M. Johannesson, and M. Silverdahl, Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity, Acta Derm Venereol, vol.80, pp.430-434, 2000.

H. Zachariae, R. Zachariae, and K. Blomqvist, Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study, Acta Derm Venereol, vol.82, pp.108-113, 2002.

G. Krueger, J. Koo, and M. Lebwohl, The impact of Ps on quality of life: results of a 1998 National Ps Foundation patient-membership survey, Arch Dermatol, vol.137, pp.280-284, 2001.

M. A. Gupta and A. K. Gupta, Quality of life of psoriasis patients, J Eur Acad Dermatol Venereol, vol.14, pp.241-242, 2000.

S. K. Kurd, A. B. Troxel, and P. Crits-christoph, The risk of depression, anxiety, and suicidality in patients with psoriasis. A population-based cohort study, Arch Dermatol, vol.146, pp.891-895, 2010.

A. B. Kimball, C. Jacobson, and S. Weiss, The psychosocial burden of psoriasis, Am J Clin Dermatol, vol.6, pp.383-392, 2005.

L. H. De-arruda, D. Moraes, and A. P. , The impact of psoriasis on quality of life, Br J Dermatol, vol.144, pp.33-36, 2001.

D. H. Ciocon, E. J. Horn, and A. B. Kimball, Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only, Am J Clin Dermatol, vol.9, pp.111-117, 2008.

M. Boers, J. R. Kirwan, and G. Wells, Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0, J Clin Epidemiol, vol.67, p.38, 2014.

M. Boers, J. R. Kirwan, and L. Gossec, How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0, J Rheumatol, vol.41, pp.1025-1030, 2014.

I. Castrejón, L. Gossec, and L. Carmona, The EULAR Outcome Measures Library: an evolutional database of validated patient-reported instruments, Ann Rheum Dis, vol.74, pp.475-476, 2015.

G. Wells, T. Li, and L. Maxwell, Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis, Ann Rheum Dis, vol.67, pp.260-265, 2008.

Y. Y. Leung, K. W. Ho, and T. Y. Zhu, Testing scaling assumptions, reliability and validity of medical outcomes study short-form 36 health survey in psoriatic arthritis, Rheumatology (Oxford), vol.49, issue.8, pp.1495-501, 2010.

J. E. Ware and C. D. Sherbourne, The RAND 36 Short-form Health Status Survey: Conceptual framework and item selection, Med Care, vol.30, pp.473-481, 1992.

J. A. Husted, D. D. Gladman, and V. T. Farewell, Validating the SF-36 health questionnaire in patients with psoriatic arthritis, J Rheumatol, vol.24, pp.511-517, 1997.

E. Group, EuroQol-a new facility for the measurement of health-related quality of life. Health Policy, vol.16, pp.199-208, 1990.

P. J. Mease, Measures of psoriatic arthritis: tender and swollen joint assessment, psoriasis area and severity index (PASI), nail psoriasis severity index (NAPSI), modified nail psoriasis severity index (mNAPSI), Mander/Newcastle enthesitis index (MEI), Leeds enthesitis index (LEI), p.39

, Canada (SPARCC)

, patient global for psoriatic arthritis, dermatology life quality index (DLQI), psoriatic arthritis quality of life (PsAQOL), functional assessment of chronic illness therapy-fatigue (FACIT-F), psoriatic arthritis response criteria (PsARC), psoriatic arthritis joint activity index (PsAJAI), Leeds dactylitis index (LDI)

, Arthritis Care Res (Hoboken), vol.63, issue.11, pp.64-85, 2011.

A. Y. Finlay and G. K. Khan, Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use, Clin Exp Dermatol, vol.19, pp.210-216, 1994.

S. R. Feldman, A. B. Kimball, and G. G. Krueger, Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial, J Am Acad Dermatol, vol.53, pp.887-889, 2005.

P. Højgaard, L. Klokker, and A. M. Orbai, A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative, Semin Arthritis Rheum, vol.9, issue.17, pp.30182-30190, 2017.

M. De-wit, T. Kvien, and L. Gossec, Patient participation as an integral part of patient reported outcomes development guarantees the representativeness of the patient voice -A case-study from the field of rheumatology, RMD Open, vol.1, pp.1-000129, 2015.

D. Carlo, M. Becciolini, A. Lato, and V. , The 12-item Psoriatic Arthritis Impact of Disease Questionnaire: Construct Validity, Reliability, and Interpretability in a Clinical Setting, J Rheumatol, vol.44, pp.279-285, 2017.

R. Holland, W. Tillett, and E. Korendowych, Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single

F. Salaffi, D. Carlo, M. Carotti, and M. , The Psoriatic Arthritis Impact of Disease 12-item questionnaire: equivalence, reliability, validity, and feasibility of the touch-screen administration versus the paper-and-pencil version, Ther Clin Risk Manag, vol.12, pp.631-642, 2016.

P. J. Healy and P. S. Helliwell, Psoriatic arthritis quality of life instrument: an assessment of sensitivity and response to change, J Rheumatol, vol.35, pp.1359-1361, 2008.

O. Gezer, ?. Batmaz, and M. A. Sariyildiz, Sleep quality in patients with psoriatic arthritis, Int J Rheum Dis, vol.20, pp.1212-1218, 2017.

D. Gladman, R. Fleischmann, and G. Coteur, Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study, Arthritis Care Res (Hoboken), vol.66, pp.1085-1092, 2014.

E. Taccari, A. Spadaro, and T. Rinaldi, Comparison of the Health Assessment Questionnaire and Arthritis Impact Measurement Scale in patients with psoriatic arthritis, Rev Rhum Engl Ed, vol.65, pp.751-758, 1998.

S. Coaccioli, A. A. Bruno, and G. Celi, Validation of an original questionnaire for patients with psoriatic arthritis: the Psoriatic Arthritis Impact Profile (PAIP), Clin Ter, vol.165, pp.100-108, 2014.

A. Chiricozzi, L. Bianchi, and A. Zangrilli, Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk, European Journal of Dermatology, vol.25, pp.64-69, 2015.

M. Y. El, G. M. El, and S. S. Youssef, Incorporating patient reported outcome measures in clinical practice: Development and validation of a questionnaire for inflammatory arthritis, Clinical and Experimental Rheumatology, vol.28, pp.734-744, 2010.

J. M. Cohen, K. Halim, and C. J. Joyce, Shedding Light on the "Hidden Psoriasis": A Pilot Study of the Inverse Psoriasis Burden of Disease (IPBOD) Questionnaire, J Drugs Dermatol, vol.15, pp.1011-1017, 2016.

L. Gossec, J. S. Smolen, and S. Ramiro, European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update, Ann Rheum Dis, vol.75, pp.499-510, 2016.

M. A. Stoffer, J. S. Smolen, and A. Woolf, Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project, Ann Rheum Dis, vol.73, pp.902-905, 2014.

J. S. Smolen, R. Landewé, and F. C. Breedveld, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update, Ann Rheum Dis, vol.73, pp.492-509, 2014.

T. C. Sanderson, S. E. Hewlett, and C. Flurey, The impact triad (severity, importance, self-management) as a method of enhancing measurement of personal life impact of rheumatic diseases, J Rheumatol, vol.38, pp.191-194, 2011.